The acquisition marks a significant strategic move for Abbott, enabling the company to expand into high-growth segments of cancer screening and diagnostics.
Exact Sciences | 23/03/2026 | By Darshana | 172
Abbott to Acquire Exact Sciences in USD 21 Billion Deal, Entering Cancer Diagnostics Sectors
After the transaction, Exact Sciences—projected to generate more than USD 3 billion in revenue this year with high-teens organic growth—will operate as a subsidiary of Abbott.
Exact Sciences | 21/11/2025 | By Dineshwori | 175
Freenome Partners with Exact Sciences to Commercialise Blood-Based Colorectal Cancer Test
Freenome has entered into an exclusive license agreement with Exact Sciences to advance the commercialisation of its colorectal cancer (CRC) blood-based screening test.
Exact Sciences | 08/08/2025 | By Dineshwori | 828
Workflow Services and Exact Sciences to Provide Easy Access of Colorectal Cancer Screening
Workflow Services has signed a new agreement with Exact Sciences, a biotechnology company that develops tests designed to prevent, detect, and guide the successful treatment of cancer.
Exact Sciences | 30/03/2024 | By Manvi | 538
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy